Optimal thrombolytic strategies for acute myocardial infarction bolus administration

QJM: An International Journal of Medicine

Volumn 91, Issue 11, 1998, Pages 719-725

  McMechan, S R ^a   Adgey, A A J ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; RETEPLASE;

ACUTE HEART INFARCTION; AGED; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BOLUS ADMINISTRATION; DRUG INFUSION; HUMAN; MORTALITY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0031736534     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.11.719     Document Type: Review

References (24)

1. The GUSTO Investigators. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-82.
2. The Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615-22.
3. Neuhaus K-L, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1989; 14:1566-9.
4. Neuhaus K-L, VonEssen R, Tebbe U, et al. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS). J Am Coll Cardiol 1992; 19:885-91.
5. Carney RJ, Murphy GA, Brandt TR, et al. Randomised angiographic trial of recombinant tissue-type plasminogen activator (Alteplase) in myocardial infarction. J Am Coll Cardiol 1992; 20:17-23.
6. Weaver WD, Cerqueira M, Hallstrom AP, et al., for the Myocardial Infarction Triage and Intervention Project Group. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993; 270:1211-16.
7. Agnelli G, Buchanan MR, Fernandez F, Hirsh J. The thrombolytic and haemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabbits. Thrombosis Res 1985; 40:769-77.
8. Cercek B, Lew AS, Yano J, Reddy KNN, Ganz W. Thrombolytic effect of recombinant tissue-type plasminogen activator administered as a bolus. Clin Res 1987; 35:102A.
9. Eisert WG, Muller TH. Bolus treatment regimen of TPA expedites rate of lysis in vivo without increasing risk of bleeding. Blood 1987; 70:(suppl 1):370a.
10. Gemmill JD, Hogg KJ, MacIntyre PD, et al. A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction. Br Heart J 1991; 66:134-8.
11. Purvis JA, McNeill AJ, Siddiqui RA, et al. Efficacy of 100mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction. J Am Coll Cardiol 1994; 23:6-10.
12. Bleich SD, Adgey AAJ, Pickering E, et al. An angiographic assessment of the efficacy and safety of front-loaded and bolus regimens of activase (alteplase recombinant). The double-bolus lytic efficacy trial (The Double Trial). Circulation 1995; 92:Suppl 1, 415.
13. The COBALT Investigators. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. N Engl J Med 1997; 337:1124-30.
14. Bode C, Smalling RW, Berg G, et al. Randomised comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. Circulation 1996; 94:891-8.
15. International Joint Efficacy Comparison of Thrombolytics. Randomised double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995; 346:329-36.
16. Dejaegere PP, Arnold AA, Balk AH, Simoons ML. Intracranial haemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors. J Am Coll Cardiol 1992; 19:289-94.
17. Sloan MA, Gore JM. Ischaemic stroke and intracranial haemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis. Am J Cardiol 1992; 69:21A-38A.
18. Gore JM, Granger CB, Simoons ML, et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-1 trial. Circulation 1995; 92:2811-18.
19. Anderson JL, Karagounis L, Allen A, Bradford MJ, Menlove RL, Pryor TA. Older age and elevated blood pressure are risk factors for intracerebral haemorrhage after thrombolysis. Am J Cardiol 1991; 68:166-70.
20. White HD, Barbash GI, Modan M, et al. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of haemorrhagic stroke. Circulation 1993; 88:2097-103.
21. Gore JM, Sloan M, Price TR, et al. Intracerebral haemorrhage, cerebral infarction and subdural haematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Circulation 1991; 83:448-59.
22. Topol E. The GUSTO III Results. Presented at Myocardial Reperfusion X: Concepts and Controversies. ACC, Anaheim 1997.
23. Ryan TJ, Anderson JL, Antman EM et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. JACC 1996; 28:1328-428.
24. Smalling RW, Bode C, Kalbfleisch J, et al. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. Circulation 1995; 91:2725-32.